• Dixie Brands (DIXI-U) subsidiary, AcesoHemp, has announced two new product lines in Healthy Beauty and Performance Management
  • Diversification of Dixie Brands’ portfolio reflects the steep growth of the CBD sector
  • AcesoHemp was also awarded a US patent for its dissolvable powders and fizzy tabs
  • Shares in Dixie Brands are currently down 5.26 per cent to C$0.18, with a market cap of C$23.02 million

Dixie Brands’ (DIXI-U) subsidiary, AcesoHemp, is adding to its product range with the addition of Healthy Beauty and Performance Management segments.

The Healthy Beauty segment will include specially designed facial moisturizers, eye creams and body lotions, while extra-strength balm and high-potency muscle roll-on gels will be included under the Performance Management segment.

A pioneer in the hemp-derived CBD sector, AcesoHemp was recently granted a US patent for its range of dissolvable powders and effervescent fizzy tabs.

“The CBD category is evolving rapidly and both consumers and retailers are becoming much clearer on what problems they’re trying to solve and the formats they’re most comfortable with,” said AecsoHemp’s Vice President of Marketing and Distribution, Hilal Tabsh.

“These exciting new product segments were specifically designed in response to those demands, providing a category solution from a brand that people know, trust and love.”

In December 2019, AcesoHemp signed a partnership agreement with Dollar General Store to place its products in over 1,110 of its retail outlets in Kentucky and Tennessee.

The same month, Dixie Brands also announced that AcesoHemp had entered a distribution agreement with Innermountain Distributing that would see its products available in retailers throughout Colorado’s Western Slope region.

Dixie Brands says that its portfolio expansion is representative of a “booming CBD category” worth over $5 billion.

Shares in the company are currently down 5.26 per cent to C$0.18, with a market cap of C$23.02 million.

More From The Market Online

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.